Odyssey Group International (ODYY) 10-K2024 FY Annual report

Filed: 13 Nov 24, 3:25pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Good

New words: al, assumption, Biographical, collateral, Condensed, contended, County, cybersecurity, dedicated, delegated, delisted, exceeding, formal, freely, Hainey, hearing, inadvertent, Island, Judge, Kent, lower, Marotti, mathematical, McCullough, merger, motion, NV, NYSE, plaintiff, pledge, pledging, predetermined, prepay, prepayment, prescribed, reconciliation, redefined, representation, Rhode, Tarro, tender, tradeable, Unrealized, Vdex, VDH, Warwick, William

Removed: abundant, accrue, aggregated, Alfred, amend, amplification, analyzed, animal, antioxidant, Ascending, ascertain, barrier, behavioral, blood, bore, brainstem, Brochure, cavity, cell, CNS, cognitive, collected, Commencement, commitment, consecutive, cortex, covenanted, customary, declared, depreciation, directed, discretionary, Dr, enrolled, fall, filled, floating, Florida, fluctuate, forecasted, fourteen, gene, hundred, inflammation, Investigator, irrespective, irrevocable, Jacob, LBL, lifespan, lipophilic, loan, LP, MAD, manufactured, margin, Master, mechanism, median, Melbourne, memory, mental, myelin, nasopharynx, neuromotor, neuroprotective, Nieman, nuclei, obligated, obligation, occurring, oxidative, palate, pandemic, partnership, passage, pathology, payroll, pediatric, placebo, predicted, prevailing, priced, progression, proliferation, promoting, proposal, recoverable, Regal, regimen, Regular, repaid, reserve, restoring, RRA, SAD, show, shown, simultaneously, single, soft, stable, stop, subcortical, suggest, sum, swelling, synthetic, Tallahassee, toxicology, traumatized, treasury, undiscounted, unit, urine, vanlandingham, variable, whatsoever, widespread

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ODYY similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification Pursuant to 18 U.S.C. Section 1350

In connection with the Annual Report of Odyssey Health, Inc. (the “Company”) on Form 10-K for the year ended July 31, 2024 as filed with the Securities and Exchange Commission (the “SEC”) on or about the date hereof (the “Report”), I, J. Michael Redmond, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.

	/s/ J. Michael Redmond
	J. Michael Redmond
	Chief Executive Officer, President and Director
	(Principal Executive Officer)

Date: November 13, 2024